PALISADE BIO, INC. Accumulated Other Comprehensive Income
PALISADE BIO, INC. (PALI) had Accumulated Other Comprehensive Income of -$2.78 thousand as of 2021-03-31, per its 10-Q filed 2021-05-14.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2021-05-14
- 2021-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$2.78K.
- 2020-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$734.00.
- 2020-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$3.99K.
- 2020-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$7.17K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2021-03-31 | -$2.78K 10-Q · filed 2021-05-14 |
| 2020-12-31 | -$734.00 10-Q · filed 2021-05-14 |
| 2020-09-30 | -$3.99K 10-Q · filed 2020-11-10 |
| 2020-06-30 | -$7.17K 10-Q · filed 2020-08-13 |
| 2020-03-31 | -$7.15K 10-Q · filed 2020-05-15 |
| 2019-12-31 | -$6.19K 10-K · filed 2021-03-22 |
| 2019-09-30 | -$7.67K 10-Q · filed 2019-11-14 |
| 2019-06-30 | -$3.17K 10-Q · filed 2019-08-14 |
| 2019-03-31 | -$2.16K 10-Q · filed 2019-05-14 |
| 2018-12-31 | -$413.00 10-K · filed 2020-03-27 |
| 2018-09-30 | $630.00 10-Q · filed 2018-11-14 |
| 2018-06-30 | $1.14K 10-Q · filed 2018-08-13 |
| 2018-03-31 | $2.75K 10-Q · filed 2018-05-15 |
| 2017-12-31 | $2.63K 10-K · filed 2019-03-22 |
| 2017-09-30 | $2.35K 10-Q · filed 2017-11-08 |
| 2017-06-30 | $3.35K 10-Q · filed 2017-08-08 |
| 2017-03-31 | $3.73K 10-Q · filed 2017-05-10 |
| 2016-12-31 | $3.90K 10-K · filed 2018-04-02 |
| 2016-09-30 | $4.59K 10-Q · filed 2016-11-08 |
| 2016-06-30 | $4.57K 10-Q · filed 2016-08-11 |
| 2016-03-31 | $1.30K 10-Q · filed 2016-05-09 |
| 2015-12-31 | $3.07K 10-K · filed 2017-03-23 |
| 2015-09-30 | $3.72K 10-Q · filed 2015-11-09 |
| 2015-06-30 | $6.00K 10-Q · filed 2015-08-10 |
| 2015-03-31 | $6.01K 10-Q · filed 2015-05-08 |
| 2014-12-31 | $6.00K 10-K · filed 2016-03-14 |
| 2014-09-30 | $6.11K 10-Q · filed 2014-11-07 |
| 2014-06-30 | $6.11K 10-Q · filed 2014-08-08 |
| 2014-03-31 | $5.98K 10-Q · filed 2014-05-12 |
| 2013-12-31 | $7.24K 10-K · filed 2015-03-16 |
| 2013-09-30 | $6.10K 10-Q · filed 2013-11-12 |
| 2012-12-31 | $0.00 10-K · filed 2014-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |